Biomarkers for Predicting Abiraterone Treatment Outcome and Selecting Alternative Therapies in Castration‐Resistant Prostate Cancer is a research paper published in Clinical Pharmacology & Therapeutics (2022). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U19 GM61388
National Institutes of Health
Grant: R01 GM28157
National Institutes of Health
Grant: R01 GM125633
U.S. Department of Defense
Grant: W81XWH‐20‐1‐0262‐01
NIGMS NIH HHS
Grant: U19 GM061388
NIGMS NIH HHS
Grant: R01 GM028157
National Institutes of Health
Grant: 2U19GM061388-11
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
National Institutes of Health
Grant: 2R01GM028157-23
Inherited Variations In Drug Metabolizing Enzymes
National Institutes of Health
Grant: 5R01GM125633-03
Pharmacogenomic regulation of CYP transcription by TSPYL genes
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals